NY-ENERGY-IMPACT
5.4.2022 09:02:08 CEST | Business Wire | Press release
Energy Impact Partners (EIP), a global venture capital firm leading the transition to a sustainable future, announced today APG Asset Management (APG) and Mainova AG (Mainova) joined the firms’ growing global coalition of industrial partners, which consists of European energy utilities and global financial asset managers. EIP works with its strategic partners in a proprietary model to find, screen and scale technologies that are critical for the global net zero carbon economy. In collaboration with its partner network, EIP shares insights, invests in innovative businesses and stimulates the growth of its portfolio companies.
“Our coalition is focused on accelerating the net zero carbon economy and adding strategic partners such as APG and Mainova are critical to the mission,” said Matthias Dill, CEO & Managing Partner at Energy Impact Partners Europe. “We are thrilled to welcome both companies to our expanding platform and look forward to working with them to scale the key technologies critical for a cleaner future. We thrive on the strength of our network and APG and Mainova will add further leverage to our efforts.”
APG and Mainova join a diverse group of industry leaders across the energy, mobility and sustainability industries including Nysnø Climate Investments, EWE, Galp and the Microsoft Climate Innovation Fund. Their participation in EIP’s global coalition furthers both companies’ commitments and strategies to contribute to innovation and reduce their carbon footprint. APG will join EIP’s ESG advisory board and Mainova will play an active role in the coalition.
“APG is committed to the energy transition in several ways and endorses the importance of long term partnerships such as with EIP’s global coalition. APG’s commitment will contribute to the impact growth of companies relevant to the energy transition thereby contributing to fulfilling society’s urgent need and ambition to become carbon neutral. APG is therefore pleased to formally announce its commitment to EIP,” said Nienke Vledder, Senior Portfolio Manager Private Investments.
“As the leading energy supplier in the Frankfurt metropolitan region, Mainova is constantly looking for new energy solutions that help our clients to become carbon neutral. EIP provides us with intelligent food for thought as well as early access to promising ideas and founders. We are looking forward to taking an active part in EIP’s coalition and to collaborating with innovative startups. They will help us and our customers to successfully get through the energy transition,” said Mainova CEO Dr. Constantin H. Alsheimer.
“EIP has for instance introduced us to Instagrid, a provider of portable power stations. Together with the startup, we have successfully tested their battery power packs. They can replace diesel gensets and thus reduce the carbon footprint of our DSO and street lighting business,” added Simon Wisseler, Senior Project Manager Corporate Strategy and Venture Capital at Mainova.
For more information on EIP, please visit www.energyimpactpartners.com .
About Energy Impact Partners
Energy Impact Partners LP (EIP) is a global venture capital firm leading the transition to a sustainable future. EIP brings together entrepreneurs and the world's most forward-looking energy and industrial companies to advance innovation. With over $2.5 billion in assets under management, EIP invests globally across venture, growth, credit, and infrastructure – and has a team of nearly 70 professionals based in its offices in New York, San Francisco, Palm Beach, London, and Cologne. For more information on EIP, please visit www.energyimpactpartners.com
.
About APG
Every day APG
is busy with something that already concerns millions of Dutch people and one day will concern millions more: pensions. APG strives to provide a good pension in a livable world for all participants, employers and pension funds. Together we work on a sustainable future in which we do not only look at prosperity, but also at well-being. Because pensions are about people, life and how we live together. So that we, our parents, and our children can enjoy a good income. Today, tomorrow, and beyond. As the largest pension provider in the Netherlands APG looks after the pensions of 4.7 million participants. APG provides executive consultancy, asset management, pension administration, pension communication and employer services. We work for pension funds and employers in the sectors of education, government, construction, cleaning, housing associations, sheltered employment organizations, medical specialists, and architects. APG manages approximately €605billion (February 2022) in pension assets. With approximately 3,000 employees we work from Heerlen, Amsterdam, Brussels, New York, Hong Kong, Shanghai and Beijing.
About Mainova
Mainova
is one of the largest regional energy suppliers in Germany and supplies about one million customers in Hesse and neighboring provinces with electricity, gas, district heating and water. Mainova also provides a wide range of energy-related products and services in areas like renewable energy, energy efficiency and e-mobility. Mainova generated around € 2.3 billion in annual revenue in 2020 with approximately 2,900 employees. Mainova was founded in 1998 and is headquartered in Frankfurt am Main, Germany.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220405005211/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
